Complex & Novel Formulation Engineering
Overcoming severe biopharmaceutical barriers to transform challenging molecules into robust, highly bioavailable clinical therapies.
The Bioavailability "Valley of Death"
Modern drug discovery is heavily skewed towards highly potent, yet notoriously insoluble molecules. The majority of these emerging assets fall into BCS Classes II and IV, presenting severe hurdles for traditional formulation approaches. When development teams rely on empirical, trial-and-error bench mixing to solve complex delivery issues, they inevitably face delayed timelines, erratic in vivo exposure, and costly clinical failures.
Precision Delivery Architectures
We engineer formulations designed to bypass physiological limitations. As your strategic co-architects, Dhee Lifesciences specialises in advanced delivery mechanisms, including amorphous solid dispersions, lipid-based systems, and targeted nano-architectures. We do not just mix excipients; we mathematically design the dosage form to strictly control pharmacokinetic exposure, ensure absolute physical stability, and guarantee seamless scalability for commercial manufacturing.
Accelerated by the SynapTx™ AI Ecosystem
Bypassing manual bench iterations. SynapTx™ synthesises vast volumes of historical excipient compatibility data and predictive biopharmaceutics to computationally model formulation viability. By simulating multivariable excipient interactions and predicting solubility outcomes before physical mixing begins, our local AI engine definitively de-risks the pathway from bench to clinic.